Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1134 | Thyroid | ECE2022

Severe hyperthyreosis

Petrak Iva , Zibar Tomšić Karin

A 72-year-old male patient presented to the ER because of general weakness, myalgia, frequent paroxysms of atrial fibrillation, shortness of breath, and hoarseness. The symptoms persisted for two months, gradually worsening and causing him to lose weight. At some point, he noticed redness of the sclera and soreness of the eyeballs. Paroxysms of rapid atrial fibrillation have been known for more than 15 years, so he had amiodarone in therapy. His initial laboratory findings sho...

ea0081ep927 | Reproductive and Developmental Endocrinology | ECE2022

Online education as effective medical training for young endocrinologist

Jambrović Martina , Nekic Anja Barac , Sambula Lana , Petrak Iva , Matas Nino , Zibar Tomšić Karin

Background: Learning through various online platforms is very common nowadays and its popularity has increased especially during the pandemic period. Nowadays, medical professionals are turning more than ever to online education through available online books, websites, and various online platforms. The aim of this study was to show that virtual training can improve the knowledge and confidence of young endocrinologists.Methods: The Croatian Section for ...

ea0081p264 | Adrenal and Cardiovascular Endocrinology | ECE2022

Mitotane side effects in the treatment of patients with adrenocortical carcinoma - a retrospective study

Barac Nekic Anja , Zibar Tomšić Karin , Sambula Lana , Matas Nino , Jambrović Martina , Petrak Iva , Dusek Tina , Kastelan Darko

Introduction: Mitotane is widely used to treat adrenocortical carcinoma (ACC) and remains the mainstay of treatment along with surgery. The aim of this study is to evaluate the adverse side effects of mitotane treatment.Materials and Methods: This retrospective study included 36 patients with ACC, ENSAT stage I- IV, who were treated with mitotane in an adjuvant or palliative setting. Patients with ENSAT stage IV who died within 6 months after surgery wer...